Adial Pharmaceuticals, Inc. (ADIL) vs Tvardi Therapeutics, Inc. (TVRD)

A side-by-side comparison of Adial Pharmaceuticals, Inc. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Adial Pharmaceuticals, Inc. logo
ADIL
Adial Pharmaceuticals, Inc.
$10M
$3.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Tvardi Therapeutics, Inc. logo
TVRD
Tvardi Therapeutics, Inc.
$10M
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ADIL vs TVRD

growth of $100 · dividends reinvested · last 1y
ADIL -77.1% (-77.1%/yr)TVRD -76.7% (-76.7%/yr)TVRD compounded faster over this window
0200400600800Start $1002026$23$23
ADIL TVRD

ADIL vs TVRD: by the numbers

  • •ADIL is the larger company ($10M vs $10M market cap).

Metrics side by side

Valuation

MetricADILTVRD
P/B ratioN/A1.21

Profitability

MetricADILTVRD
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-37052.06%-310.94%
ROIC-240.64%-323.71%

Growth (annualized)

MetricADILTVRD
Total return CAGR (5Y)-71.86%N/A

Go deeper

Full ADIL analysisFull TVRD analysisInteractive comparison tool

Dig into the metrics

Adial Pharmaceuticals ROETvardi Therapeutics ROEAdial Pharmaceuticals operating marginTvardi Therapeutics operating marginAdial Pharmaceuticals revenue growthTvardi Therapeutics revenue growthAdial Pharmaceuticals free cash flowTvardi Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.